IP Library Granted Patent US 9,775,911
Granted Patent B2
US 9,775,911 · App. 15/170,827 · Granted Oct 3, 2017

Composition comprising a polymeric reagent

Inventors: Michael D. Bentley (Huntsville, AL); Sean M. Culbertson (Gurley, AL); Samuel P. McManus (Guntersville, AL)
Assignee: Nektar Therapeutics
A61K47/48215A61K38/26A61K38/28C07C235/68C07D207/46C07K14/575C08G61/02C08G65/338C08G65/3348C08G65/33396C08G65/48C08K5/13A61K31/765C08K2201/012
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,775,911
App. No.
15/170,827
Granted
Oct 3, 2017
Kind
B2
Abstract

The present invention provides among other things a composition of a polymeric reagent and an antioxidant, such as butylated hydroxyl toluene.

Claims (17)

1. A composition, comprising

(a) a polymeric reagent having the following structure:

wherein

POLY 1 is a first poly(alkylene glycol),

POLY 2 is a second poly(alkylene glycol),

X 1 is a first spacer moiety, and

X 2 is a second spacer moiety, and

(b) an antioxidant.

2. The composition of claim 1 , wherein each of POLY′ and POLY is a poly(ethylene glycol).

3. The composition of claim 2 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 120 Daltons to about 6,000 Daltons.

4. The composition of claim 2 , wherein each poly(ethylene glycol) has a weight-average molecular weight in the range of from about 6,000 Daltons to about 100,000 Daltons.

5. The composition of claim 1 , wherein the first spacer moiety is selected from the group consisting of —NH—C(O)—, —NH—C(O)—CH 2 —, —NH—C(O)—CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —NH—C(O)—CH 2 —O—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, and —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—, and the second spacer moiety is selected from the group consisting of —NH—C(O)—, —NH—C(O)—CH 2 —, —NH—C(O)—CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —, —NH—C(O)—CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—C(O)—CH 2 —CH 2 —CH 2 —CH 2 —CH 2 —C(O)—, —NH—CH 2 —CH 2 —(OCH 2 CH 2 ) 1-3 —NH—C(O)—, —NH—C(O)—CH 2 —O—, —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —, and —NH—C(O)—CH 2 —CH 2 —CH 2 —C(O)—NH—CH 2 —CH 2 —O—.

6. The composition of claim 1 , wherein the polymeric reagent corresponds to the following formula:

wherein each (n) is from 4 to 1500.

7. The composition of claim 1 , wherein the polymeric reagent corresponds to the following formula:

wherein each (n) is from 4 to 1500.

8. The composition of claim 1 , wherein the antioxidant is butylated hydroxyl toluene.

Assignments (2)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
SECURITY INTEREST Recorded Jul 8, 2016
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 039111/0745 →
Continuity (12)
Continuation 14807244 · Jul 23, 2015
Continuation 14570705 · Dec 15, 2014
Continuation 14109302 · Dec 17, 2013
Continuation 13788179 · Mar 7, 2013
Continuation 13525068 · Jun 5, 2012
Continuation 11454971 · Jun 16, 2006
Provisional Application 60752825 · Dec 21, 2005
Provisional Application 60751082 · Dec 16, 2005
Provisional Application 60751121 · Dec 16, 2005
Provisional Application 60705968 · Aug 4, 2005
Provisional Application 60691516 · Jun 16, 2005
Related Publication 20160324973A1 · Nov 10, 2016